NASDAQ: IOSP

Innospec (IOSP) Stock Analysis & Forecast

Oct 12 close

$95.66+0.01 (0.0%)

Gekko Brief

AI summaryOct 12 close

Innospec's week centers on its scheduled Q3 2026 earnings release, confirmed for 3 November with a conference call the following day hosted by CEO Patrick S. Williams and CFO Ian Cleminson. Coverage also revisited the Q2 2026 results, with revenue of $491.4 million, up 12% year-over-year, and adjusted EPS that exceeded consensus estimates, alongside double-digit growth across segments and Performance Chemicals operating income up 15%. Argus raised its price target on the stock to $103.00. Separately, a passive holder disclosed a 4.7% stake of 1,161,421 shares via a Schedule 13G filing.

The stock closed at $95.66, sitting above both its 50-day average of $94.17 and its 200-day average of $82.97, with the shorter average above the longer one, reflecting a supportive trend. Shares have gained 2.6% over one month, 17.2% over three months, and 25.4% over the past year, trading within a 52-week range of $65.51 to $100.48. The GekkoIndex reads 56, placing it in the Neutral zone, while price sits about 1% below Gekko Fair Value of $96.67.

Earnings arrive on 3 November, 21 days out, falling inside a typical 20-trading-day holding window, with the last report producing a 7.6% reaction and six beats in eight quarters. No insider, Congress, or options activity appears in their respective windows. Seasonally, the next 20 trading days from this point have averaged an 8.5% gain over 5 years, positive in 4 of them, a pattern worth noting alongside the upcoming report.

Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.

Innospec price vs fair value

$96.67$95.66Oct ’25Apr ’26Oct ’26
Close $95.66200-day averageGekko Fair Value $96.67

Innospec quick facts

Market cap
$2.36B
P/E ratio
19.9
Forward P/E
15
EPS, TTM
$4.90
Revenue, TTM
$1.84B
Profit margin
6.6%
Dividend yield
1.84%
Beta
0.89
Volume
167,066 avg 232,362
1-year return
+25.4%
Typical daily move
±2.3%
Typical 20-day move
±5.1%
50-day average
$94.17
200-day average
$82.97
Next earnings
Nov 3
Shares outstanding
24.63M
52-week range
$65.51$100.48

Innospec swing-trade checklist

Innospec scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive2 mixed1 headwind

  • Trendsupportive

    Above 50 and 200-day

    Close $95.66 is above the 50-day ($94.17) and 200-day ($82.97) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    56, Neutral

    Reading 56 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuemixed

    1.0% below

    Price is within 5% of Gekko Fair Value (1% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings riskheadwind

    Reports in 22 days

    Reports on Nov 3, 2026, 22 days away — inside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +8.5% on average

    From this point in the calendar, the next 20 trading days averaged +8.5% over 5 years, rising in 4 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Innospec stock chart and price history

Innospec closed at $95.66 on Oct 12, 2026, +25.4% over the past year, inside a 52-week range of $65.51 to $100.48.

Close50-day average200-day averageVolume
Innospec share price, past year, with 50-day and 200-day moving averages and volume$70$80$90$100NovDecJan 2026FebMarAprMayJunJulAugSepOct95.66

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+2.6%
3 months
+17.2%
6 months
+24.9%
1 year
+25.4%
The full IOSP chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open IOSP in Gekko

Follow Innospec through every session

Put IOSP on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track IOSP in GekkoFree for 7 days. No credit card required.

About Innospec

Innospec makes specialty chemicals that go into fuel, personal care, agriculture, and oil extraction work. Its additives help engines run in cars, ships, and planes, and they also show up in generators and heating oil setups. Buyers span fuel makers, industrial firms, and companies in oil and gas.

The company runs three main lines of business. One, Fuel Specialties, builds additive blends for engines and fuel systems. Another, Performance Chemicals, supplies formulations for personal care, household goods, crop chemicals, and metal recovery work. The third, Oilfield Services, focuses on chemicals that support fracturing, well stimulation, and completion, along with products used in extraction and drilling fluid management. Its customer base includes oil and gas producers, refiners, fuel distributors, personal and home care brands, agrochemical formulators, and other industrial users.

The company began in 1938 under the name Octel Corp, later taking the Innospec name in 2006. It runs out of Englewood, Colorado, and does business across the United States, the rest of North America, the UK, continental Europe, and other markets abroad. Its stock trades on the NASDAQ under the ticker IOSP.

Listed
NASDAQ
Sector
Process industries
Industry
Chemicals: major diversified
Website
innospec.com

Innospec GekkoIndex: the smart money zone

Innospec’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56, in the Neutral zone, up 5.4 points over five sessions.

010056Neutral

Up 5.4 points over five sessions.

Reading for Oct 12, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying59+1.0%+1.5%+3.4%+2.9%
Accumulation226−0.3%−0.1%−0.5%−2.9%
Neutral (current zone)3540.0%−0.2%−0.5%−1.2%
Distribution40−0.9%−2.2%−4.3%−3.3%
Selling3Too few readings yet

Average IOSP share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the IOSP price, zone by zone.Track IOSP in Gekko

Is Innospec stock overvalued? Gekko Fair Value

Innospec trades 1.0% below Gekko Fair Value of $96.67, so the shares are about fair value on Gekko’s estimate.

Gekko’s own estimate of what Innospec shares are worth, recalculated every trading day.

$96.67

Gekko Fair Value, Oct 10, 2026

1.0% below fair value · About fair value

At the end of Aug 2026 the price was 5.1% below the estimate.

Gekko Fair ValueShare price, month end
$97$96Aug 2026SepOct 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open IOSP in Gekko

Innospec insider and Congress trading

No open-market insider purchases were filed for Innospec, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for IOSP in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every IOSP insider filing, plotted on the chart in Gekko.Open IOSP in Gekko

Congress trades last 90 days

No trades in IOSP were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for IOSP, plotted on the chart in Gekko.Open IOSP in Gekko

Buybacks

Innospec has been buying back its own shares.

Latest authorization
$75.00M, May 8, 2026
Bought back, quarter ended Jun 30, 2026
$6.40M
As a share of market cap
0.27%

From company filings.

Innospec earnings: next date and track record

Innospec reports on Nov 3, 2026 (22 days away), and beat the EPS estimate in 6 of its last 8 reports.

6 of 8reports beat the EPS estimate
±4.4%average move across the report
4 of 8reports followed by a gain

Share-price move across each report

+14.7%Nov ’24−5.5%Feb ’25−1.7%May ’25−1.4%Aug ’25+0.5%Nov ’25−0.3%Feb ’26+3.7%May ’26+7.6%Aug ’26

Last earnings call, Aug 4, 2026 AI summary

What they said
Innospec reported Q2 revenue of $491.4M, up 12% year-over-year, with net income of $30.8M versus $23.5M prior year. Adjusted EPS was $1.27 versus $1.26 last year. Performance Chemicals operating income rose 15%, Fuel Specialties operating income grew 3%, and Oilfield Services operating income surged 40%. The company holds $250.2M cash with no debt and repurchased 87K shares for $6.4M.
Guidance
Management expects continued improvement in H2 2026 across all segments. Fuel Specialties may face sequential margin headwinds from pricing-cost inflation lag. Oilfield Services anticipates sequential improvement driven by DRA plant expansion and Middle East recovery.
ReportedEPSSurpriseRevenueSurpriseMove
Aug 4, 2026$1.27
est $1.05
+21.0%$491.4M
est $457.2M
+7.5%+7.6%
May 7, 2026$1.05
est $1.32
−20.5%$453.2M
est $432.1M
+4.9%+3.7%
Feb 17, 2026$1.50
est $1.26
+19.0%$455.6M
est $460.9M
−1.1%−0.3%
Nov 4, 2025$1.12
est $1.03
+8.7%$441.9M
est $460.9M
−4.1%+0.5%
Aug 5, 2025$1.26
est $1.17
+7.7%$439.7M
est $450.0M
−2.3%−1.4%
May 8, 2025$1.42
est $1.40
+1.4%$440.8M
est $467.6M
−5.7%−1.7%
Feb 18, 2025$1.41
est $1.36
+3.7%$466.8M
est $447.4M
+4.3%−5.5%
Nov 5, 2024$1.35
est $1.35
0.0%$443.4M
est $454.9M
−2.5%+14.7%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Innospec stock forecast and analyst price targets

Analysts’ average 12-month price target for Innospec is $101.00, +5.6% from the last close, from 1 firm rating the stock in the last 90 days.

$101.00consensus 12-month target, +5.6% from the last close
Buy1
Hold0
Sell0

Each firm’s latest rating in the last 90 days: 1 firm.

Latest analyst actions

DateFirmRatingTargetvs price
Aug 6Seaport GlobalBuy, maintained$110+15.0%
−0.5%average 20-day move after past Neutral readings
+8.5%average move over the next 20 trading days in the last 5 years
±2.3%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Innospec seasonality: the next 20 trading days

Over the next 20 trading days from Oct 10, Innospec averaged +8.5% across the last 5 years, rising in 4 of them.

Next 20 trading days, by year

+11.4%2021+18.5%2022−2.6%2023+7.4%2024+3.4%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+2.3%4 of 5
Next 10 trading days+1.8%3 of 5
Next 15 trading days+3.5%2 of 5
Next 20 trading days+8.5%4 of 5
Next 30 trading days+8.3%4 of 5

For scale, IOSP’s typical 20-trading-day move in either direction is about 5.1%.

Innospec market cap and key statistics

Innospec’s market cap is $2.36B, with a P/E ratio of 19.9 and revenue of $1.84B over the last twelve months.

Valuation

Market cap
$2.36B
P/E ratio
19.9
Forward P/E
15
EPS, TTM
$4.90
Gekko Fair Value
$96.67

Trading

Volume
167,066
Avg volume, 20 days
232,362
52-week high
$100.48
52-week low
$65.51
Shares outstanding
24.63M

Financials

Revenue, TTM
$1.84B
Profit margin
6.6%
Return on equity
9.1%
Quarterly earnings growth, YoY
+33.0%

Risk and income

Beta
0.89
Typical daily move
±2.3%
Typical 20-day move
±5.1%
Dividend yield
1.84%

Innospec stock news this week

Coverage of Innospec this week reads neutral: 5 positive, 10 neutral and 0 negative headlines.

News sentiment neutral

Innospec peers

Innospec’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
DDDuPont de Nemours−0.2%Accumulation5.8% above
SOLSSolstice Advanced Materials−0.8%Neutral44.8% below
ESIElement Solutions+1.5%Neutral10.1% above
PRMPerimeter Solutions−1.5%Accumulation24.0% below
AVNTAvient+3.1%Buying36.4% below
NGVTIngevity−0.2%Accumulation12.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

Innospec stock FAQ

What is Innospec’s market cap?

Innospec’s market cap is $2.36B at the Oct 12, 2026 close of $95.66, with 24.63M shares outstanding. The shares trade on a P/E ratio of 19.9.

What is the Innospec stock forecast?

The consensus analyst 12-month price target for Innospec is $101.00, +5.6% from the last close. Of the 1 firm that rated the stock in the last 90 days, 1 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Innospec stock overvalued or undervalued?

On Gekko’s estimate Innospec is about fair value: the Oct 12, 2026 close of $95.66 is 1.0% below Gekko Fair Value of $96.67. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Innospec report earnings next?

Innospec is expected to report on Nov 3, 2026 (22 days away). Analysts expect earnings of $1.27 per share on revenue of $478.3M. Innospec beat the earnings estimate in 6 of its last 8 reports, moving 4.4% on average across the report.

What is Innospec’s 52-week high and low?

Innospec’s 52-week high is $100.48 and its 52-week low is $65.51; it closed at $95.66 on Oct 12, 2026, +25.4% over the past year. Over the last five years the shares peaked at $133.71 on May 10, 2024.

Is Innospec stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and seasonality), 2 as mixed (gekkoindex and fair value) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Innospec the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,408 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.